Bayer Will Acquire AskBio for Up to $4 Billion
Bayer has faced several hardships recently, and sees the acquisition of AskBio as a way to move forward with the drug making arm of its business.
Read moreBayer has faced several hardships recently, and sees the acquisition of AskBio as a way to move forward with the drug making arm of its business.
Read moreCompared to its big tech peers, Facebook has been slower to dive into cloud-based gaming, but it hopes to gradually grow its user base over the next decade.
Read moreAnt Group, the Chinese fin-tech company, is planning an IPO in Hong Kong and Shanghai. Ant’s payment service has 730 million monthly users, which is more than twice the population of the US.
Read moreTensions between EV battery makers and car producers have been high recently. There have been intellectual property disagreements, logistics difficulties, supply chain disruptions, and product recalls.
Read moreHow will markets look after Nov. 3, and what sectors should investors keep an eye on post-Election Day?
Read more